Marcela Maria Baracat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marcela Maria Baracat has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Waldiceu Aparecido Verri
Laboratory of Pain, Inflammation, Neuropathy and Cancer, Department of Immunology, Parasitology, and General Pathology, Londrina State University, Londrina 86057-970, Brazil
24 shared publications - Rubia Casagrande
Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86057-970, Brazil
20 shared publications - Renata M. Martinez
Department of Pharmaceutical Sciences, State University of Londrina, Londrina 3371-2475, PR, Brazil
14 shared publications - Sandra Regina Georgetti
Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina-UEL, Avenida Robert Koch, 60, Hospital Universitário, 86039-440 Londrina, Paraná, Brazil
13 shared publications - Fabiana Testa Moura de Carvalho Vicentini
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-903, SP, Brazil
9 shared publications - Priscila Saito
Department of Pharmaceutical Sciences, Centre of Health Science, Londrina State University, Avenida Robert Koch, 60, Londrina 86038-350, PR, Brazil
8 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 76
Pathophysiological Mechanisms of UVB Irradiation in the Skin: Inflammation, Oxidative Stress and Neuroimmune Interactions
Ultraviolet B (UVB) irradiation, with wavelengths ranging from 290 to 320 nm, represents a biologically active fraction of solar irradiation that reaches the Earth’s surface and exerts significant effects on human skin. Due to its high energy, UVB penetrates the epidermis and directly interacts with cellular components, particularly DNA, leading to the formation of photoproducts such as cyclobutane pyrimidine dimers. In parallel, UVB exposure induces the generation of reactive oxygen species, promoting oxidative stress and damage to lipids, proteins, and genetic material. These events activate key intracellular signaling pathways, including NF-κB and MAPKs, resulting in the production of pro-inflammatory mediators that amplify cutaneous inflammation. In addition to classical inflammatory and oxidative mechanisms, emerging evidence highlights the role of neuroimmune interactions in the skin, involving crosstalk between nerve endings, neuropeptides, and immune cells, which contributes to the regulation of local immune responses following UVB exposure. The integration of these processes plays a central role in the pathophysiology of UVB-induced skin damage and in the development of skin diseases. This review will discuss the molecular and cellular mechanisms underlying the cutaneous response triggered by UVB irradiation, with emphasis on inflammation, oxidative stress, and neuroimmune communication. Additionally, current and emerging therapeutic strategies based on pathophysiology mechanisms, including antioxidant agents, anti-inflammatory compounds, and photoprotective approaches, will be discussed to highlight potential avenues for improved prevention and treatment of UVB-induced skin damage.
- 8 October 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 76
Open AccessPathophysiological Mechanisms of UVB Irradiation in the Skin: Inflammation, Oxidative Stress and Neuroimmune Interactions
Ultraviolet B (UVB) irradiation, with wavelengths ranging from 290 to 320 nm, represents a biologically active fraction of solar irradiation that reaches the Earth’s surface and exerts significant effects on human skin. Due to its high energy, UVB penetrates the epidermis and directly interacts with cellular components, particularly DNA, leading to the formation of photoproducts such as cyclobutane pyrimidine dimers. In parallel, UVB exposure induces the generation of reactive oxygen species, promoting oxidative stress and damage to lipids, proteins, and genetic material. These events activate key intracellular signaling pathways, including NF-κB and MAPKs, resulting in the production of pro-inflammatory mediators that amplify cutaneous inflammation. In addition to classical inflammatory and oxidative mechanisms, emerging evidence highlights the role of neuroimmune interactions in the skin, involving crosstalk between nerve endings, neuropeptides, and immune cells, which contributes to the regulation of local immune responses following UVB exposure. The integration of these processes plays a central role in the pathophysiology of UVB-induced skin damage and in the development of skin diseases. This review will discuss the molecular and cellular mechanisms underlying the cutaneous response triggered by UVB irradiation, with emphasis on inflammation, oxidative stress, and neuroimmune communication. Additionally, current and emerging therapeutic strategies based on pathophysiology mechanisms, including antioxidant agents, anti-inflammatory compounds, and photoprotective approaches, will be discussed to highlight potential avenues for improved prevention and treatment of UVB-induced skin damage.
- Open Access
Flavonoids as Nutraceuticals to Treat Inflammatory Diseases: Focusing on Quercetin, Kaempferol, Luteolin, Apigenin, Epicatechin and Their Effects on Hepatic, Nervous, and Pulmonary Systems
The immune response is essential in the protection of our body against pathogens; however, the inflammatory response caused by the immune system can become a disease itself. In fact, anti-inflammatory and immune-suppressive drugs are applied to limit the immune response to treat inflammatory diseases. Flavonoids are plant-derived polyphenols extensively investigated for their anti-inflammatory and antioxidant properties in inflammatory diseases. Studies applying isolated compounds as well as using supplements as nutraceuticals based on flavonoids have been conducted. Our review systematically analyzed the top five studied flavonoids between 2020 and 2025: quercetin (1742 articles), kaempferol (642), luteolin (589), apigenin (419), and epicatechin (354), highlighting their major therapeutic applications in diseases affecting the liver (12%), nervous system (11%), and lungs (10%). Mechanistically, these compounds act as multi-target agents mainly by inhibiting NF-κB and inducing Nrf2-dependent antioxidant programs. Application of advanced delivery systems, which increase oral bioavailability by up to 20-fold, overcomes pharmacokinetic bottlenecks. Clinical highlights demonstrated promising therapeutic effects, including reduced intrahepatic lipid accumulation in non-alcoholic fatty liver disease patients following quercetin supplementation (11.5% to 9.6%) and accelerated SARS-CoV-2 clearance after quercetin phytosome administration. The translation of flavonoids into standardized clinical therapies remains limited by the lack of large-scale, well-controlled clinical trials.
Open AccessFlavonoids as Nutraceuticals to Treat Inflammatory Diseases: Focusing on Quercetin, Kaempferol, Luteolin, Apigenin, Epicatechin and Their Effects on Hepatic, Nervous, and Pulmonary Systems
The immune response is essential in the protection of our body against pathogens; however, the inflammatory response caused by the immune system can become a disease itself. In fact, anti-inflammatory and immune-suppressive drugs are applied to limit the immune response to treat inflammatory diseases. Flavonoids are plant-derived polyphenols extensively investigated for their anti-inflammatory and antioxidant properties in inflammatory diseases. Studies applying isolated compounds as well as using supplements as nutraceuticals based on flavonoids have been conducted. Our review systematically analyzed the top five studied flavonoids between 2020 and 2025: quercetin (1742 articles), kaempferol (642), luteolin (589), apigenin (419), and epicatechin (354), highlighting their major therapeutic applications in diseases affecting the liver (12%), nervous system (11%), and lungs (10%). Mechanistically, these compounds act as multi-target agents mainly by inhibiting NF-κB and inducing Nrf2-dependent antioxidant programs. Application of advanced delivery systems, which increase oral bioavailability by up to 20-fold, overcomes pharmacokinetic bottlenecks. Clinical highlights demonstrated promising therapeutic effects, including reduced intrahepatic lipid accumulation in non-alcoholic fatty liver disease patients following quercetin supplementation (11.5% to 9.6%) and accelerated SARS-CoV-2 clearance after quercetin phytosome administration. The translation of flavonoids into standardized clinical therapies remains limited by the lack of large-scale, well-controlled clinical trials.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 62
PHOTOPROTECTIVE EFFICACY OF ROBUSTA GREEN COFFEE (Coffea canephora) EXTRACT AND LINSEED (Linum usitatissimum) OIL-BASED NANOEMULSIONS AGAINST UVB-INDUCED DAMAGE TO THE SKIN
This study adopted a preclinical model to develop and evaluate the photoprotective efficacy of nanoemulsions (NEs) containing Robusta green coffee extract (GCE) and linseed oil (LO) against UVB-induced skin damage. The GCE, rich in polyphenols and caffeine, demonstrated antioxidant activity in vitro. The LO met quality standards based on physicochemical analyses (peroxide, acid, and saponification values), confirming its suitability for formulation. Using Chremophor® RH 40 and Span® 80 as surfactants yielded stable and nanometric NEs, since both the control with only LO (NE-C) and the NEs loaded with GCE at concentrations of 0.25% (NE-0.25), 0.5% (NE-0.5), and 1.0% (NE-1.0) showed D50 < 90 nm, PDI ≤ 0.2, and ZP < -26.0 mV. Morphological studies confirmed a spherical shape and uniform droplet distribution, with no aggregation. Moreover, all NEs presented a pH of around 5, compatible with human skin. The NEs were topically applied to the dorsal skin of hairless mice before and after UVB exposure. Besides being well tolerated following an acute irritation test, NE-0.25 markedly reduced neutrophil migration (49%) while recovering the skin antioxidant capacity (catalase activity and reduced glutathione levels) to near-baseline values within 12 h of UVB exposure, thus highlighting its potential as a skin anti-aging strategy.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 62
Open AccessPHOTOPROTECTIVE EFFICACY OF ROBUSTA GREEN COFFEE (Coffea canephora) EXTRACT AND LINSEED (Linum usitatissimum) OIL-BASED NANOEMULSIONS AGAINST UVB-INDUCED DAMAGE TO THE SKIN
This study adopted a preclinical model to develop and evaluate the photoprotective efficacy of nanoemulsions (NEs) containing Robusta green coffee extract (GCE) and linseed oil (LO) against UVB-induced skin damage. The GCE, rich in polyphenols and caffeine, demonstrated antioxidant activity in vitro. The LO met quality standards based on physicochemical analyses (peroxide, acid, and saponification values), confirming its suitability for formulation. Using Chremophor® RH 40 and Span® 80 as surfactants yielded stable and nanometric NEs, since both the control with only LO (NE-C) and the NEs loaded with GCE at concentrations of 0.25% (NE-0.25), 0.5% (NE-0.5), and 1.0% (NE-1.0) showed D50 < 90 nm, PDI ≤ 0.2, and ZP < -26.0 mV. Morphological studies confirmed a spherical shape and uniform droplet distribution, with no aggregation. Moreover, all NEs presented a pH of around 5, compatible with human skin. The NEs were topically applied to the dorsal skin of hairless mice before and after UVB exposure. Besides being well tolerated following an acute irritation test, NE-0.25 markedly reduced neutrophil migration (49%) while recovering the skin antioxidant capacity (catalase activity and reduced glutathione levels) to near-baseline values within 12 h of UVB exposure, thus highlighting its potential as a skin anti-aging strategy.
- Open Access
- 7 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (32) , 36056-36067
Targeted-Produced Dirhamnolipids from Pseudomonas aeruginosa Induce Antinociception in Mice
Rhamnolipids are highly effective surface-active glycolipid biosurfactants with enormous market potential. Composed of β-d-(β-d-hydroxyalkanoyloxy)-alkanoic acids attached to mono- or dirhamnose moieties, these green amphiphilic molecules exhibit remarkable biomedical prospects, with the double rhamnose congeners being the most effective ones. Although reports on dirhamnolipid antimicrobial activities and wound healing properties are quite abundant, the antinociceptive effect on inflammatory pain has never been tested before. Here we report a targeted-producing dirhamnolipid process, which reaches 95.1% of dirhamnolipid abundance, followed by a single-step purification procedure through a homemade silica cartridge, achieving highly pure glycolipid (99.0% rhamnolipids and 97.5% dirhamnolipids). Purified Di-RL (pDi-RL) therapeutic effects were investigated in murine models of pain and inflammation induced by carrageenan, acetic acid, and formalin. Mice were pretreated with pDi-RL at doses of 0.3 and 3 mg/kg, subcutaneously, 30 min before the inflammatory stimulation. pDi-RL at the 3 mg/kg dose reduced the mechanical sensitivity and leukocyte infiltrate in the cutaneous plantar skin induced by carrageenan and overt pain-like behaviors induced by formalin and acetic acid. Furthermore, the pDi-RL mechanisms were assessed in a peritonitis model induced by carrageenan, and pDi-RL reduced the total leukocyte recruitment (mononuclear and polymorphonuclear cells) and superoxide anion production by recruiting leukocytes in the peritoneal exudate. Here, we demonstrate for the first time the antinociceptive activity of Di-RL and, at least in part, its mechanism in murine models of pain and inflammation.
- 7 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (32) , 36056-36067
Open AccessTargeted-Produced Dirhamnolipids from Pseudomonas aeruginosa Induce Antinociception in Mice
Rhamnolipids are highly effective surface-active glycolipid biosurfactants with enormous market potential. Composed of β-d-(β-d-hydroxyalkanoyloxy)-alkanoic acids attached to mono- or dirhamnose moieties, these green amphiphilic molecules exhibit remarkable biomedical prospects, with the double rhamnose congeners being the most effective ones. Although reports on dirhamnolipid antimicrobial activities and wound healing properties are quite abundant, the antinociceptive effect on inflammatory pain has never been tested before. Here we report a targeted-producing dirhamnolipid process, which reaches 95.1% of dirhamnolipid abundance, followed by a single-step purification procedure through a homemade silica cartridge, achieving highly pure glycolipid (99.0% rhamnolipids and 97.5% dirhamnolipids). Purified Di-RL (pDi-RL) therapeutic effects were investigated in murine models of pain and inflammation induced by carrageenan, acetic acid, and formalin. Mice were pretreated with pDi-RL at doses of 0.3 and 3 mg/kg, subcutaneously, 30 min before the inflammatory stimulation. pDi-RL at the 3 mg/kg dose reduced the mechanical sensitivity and leukocyte infiltrate in the cutaneous plantar skin induced by carrageenan and overt pain-like behaviors induced by formalin and acetic acid. Furthermore, the pDi-RL mechanisms were assessed in a peritonitis model induced by carrageenan, and pDi-RL reduced the total leukocyte recruitment (mononuclear and polymorphonuclear cells) and superoxide anion production by recruiting leukocytes in the peritoneal exudate. Here, we demonstrate for the first time the antinociceptive activity of Di-RL and, at least in part, its mechanism in murine models of pain and inflammation.
- Open Access
- 6 July 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (7) , 830
Resolvin D2 Reduces UVB Skin Pathology by Targeting Cytokines, Oxidative Stress, and NF-κB Activation
UVB skin pathology is initiated by reactive oxygen species (ROS), differentiating this condition from other inflammatory diseases involving first the immune cell activation by danger or pathogen molecular patterns followed by oxidative stress. Resolvin D2 (RvD2) has been found to reduce inflammation in preclinical models. However, whether or not RvD2 reduces skin pathology caused by UVB irradiation is not yet known. Therefore, the efficacy of RvD2 on skin pathology triggered by UVB irradiation in female hairless mice was assessed. RvD2 (0.3, 1 or 3 ng/mouse, i.p.) was found to protect the skin against UVB inflammation, as observed in the reduction in edema (46%), myeloperoxidase activity (77%), metalloproteinase-9 activity (39%), recruitment of neutrophils/macrophages (lysozyme+ cells, 76%) and mast cells (106%), epidermal thickening (93%), sunburn cell formation (68%), collagen fiber breakdown (55%), and production of cytokines such as TNF-α (100%). Considering the relevance of oxidative stress to UVB irradiation skin pathologies, an important observation was that the skin antioxidant capacity was recovered by RvD2 according to the results that show the ferric reducing antioxidant power (68%), cationic radical scavenges (93%), catalase activity (74%), and the levels of reduced glutathione (48%). Oxidative damage was also attenuated, as observed in the reduction in superoxide anion production (69%) and lipid hydroperoxides (71%). The RvD2 mechanism involved the inhibition of NF-κB activation, as observed in the diminished degradation of IκBα (48%) coupled with a reduction in its downstream targets that are involved in inflammation and oxidative stress, such as COX-2 (66%) and gp91phox (77%) mRNA expression. In conclusion, RvD2 mitigates the inflammatory and oxidative pathologic skin aggression that is triggered by UVB.
- 6 July 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (7) , 830
Open AccessResolvin D2 Reduces UVB Skin Pathology by Targeting Cytokines, Oxidative Stress, and NF-κB Activation
UVB skin pathology is initiated by reactive oxygen species (ROS), differentiating this condition from other inflammatory diseases involving first the immune cell activation by danger or pathogen molecular patterns followed by oxidative stress. Resolvin D2 (RvD2) has been found to reduce inflammation in preclinical models. However, whether or not RvD2 reduces skin pathology caused by UVB irradiation is not yet known. Therefore, the efficacy of RvD2 on skin pathology triggered by UVB irradiation in female hairless mice was assessed. RvD2 (0.3, 1 or 3 ng/mouse, i.p.) was found to protect the skin against UVB inflammation, as observed in the reduction in edema (46%), myeloperoxidase activity (77%), metalloproteinase-9 activity (39%), recruitment of neutrophils/macrophages (lysozyme+ cells, 76%) and mast cells (106%), epidermal thickening (93%), sunburn cell formation (68%), collagen fiber breakdown (55%), and production of cytokines such as TNF-α (100%). Considering the relevance of oxidative stress to UVB irradiation skin pathologies, an important observation was that the skin antioxidant capacity was recovered by RvD2 according to the results that show the ferric reducing antioxidant power (68%), cationic radical scavenges (93%), catalase activity (74%), and the levels of reduced glutathione (48%). Oxidative damage was also attenuated, as observed in the reduction in superoxide anion production (69%) and lipid hydroperoxides (71%). The RvD2 mechanism involved the inhibition of NF-κB activation, as observed in the diminished degradation of IκBα (48%) coupled with a reduction in its downstream targets that are involved in inflammation and oxidative stress, such as COX-2 (66%) and gp91phox (77%) mRNA expression. In conclusion, RvD2 mitigates the inflammatory and oxidative pathologic skin aggression that is triggered by UVB.
- 13 January 2025
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 207, 114631
Patches containing quercetin microcapsules to ameliorate dermal herpes simplex virus injuries in mice
- 13 January 2025
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 207, 114631
Patches containing quercetin microcapsules to ameliorate dermal herpes simplex virus injuries in mice
- Open Access
- 19 August 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (8) , 1008
Resolvin D5 Protects Female Hairless Mouse Skin from Pathological Alterations Caused by UVB Irradiation
Resolvin D5 (RvD5) is a lipid mediator that has been reported to present anti-inflammatory and pro-resolution properties. Evidence also supports its capability to enhance reactive oxygen species (ROS) production during bacterial infections, which would be detrimental in diseases driven by ROS. The biological activity of RvD5 and mechanisms against UVB irradiation skin pathology have not been investigated so far. Female hairless mice were treated intraperitoneally with RvD5 before UVB stimulus. RvD5 reduced skin edema in a dose-dependent manner as well as oxidative stress by increasing antioxidants (endogenous tissue antioxidant scavenging of cationic radical, iron reduction, catalase activity and reduced glutathione levels) and decreasing pro-oxidants (superoxide anion and lipid peroxidation). RvD5 antioxidant activity was accompanied by enhancement of Nrf2, HO-1 and NQO1 mRNA expression. RvD5 reduced the production of IL-1β, TNF-α, TGF-β, and IL-10. RvD5 also reduced the inflammatory cell counts, including mast cells and neutrophils/macrophages. The reduction of oxidative stress and inflammation resulted in diminished matrix metalloproteinase 9 activity, collagen degradation, epidermal thickening and sunburn cell development. Therefore, this study demonstrates, to our knowledge, the first body of evidence that RvD5 can be used to treat UVB skin pathology and unveils, at least in part, its mechanisms of action.
- 19 August 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (8) , 1008
Open AccessResolvin D5 Protects Female Hairless Mouse Skin from Pathological Alterations Caused by UVB Irradiation
Resolvin D5 (RvD5) is a lipid mediator that has been reported to present anti-inflammatory and pro-resolution properties. Evidence also supports its capability to enhance reactive oxygen species (ROS) production during bacterial infections, which would be detrimental in diseases driven by ROS. The biological activity of RvD5 and mechanisms against UVB irradiation skin pathology have not been investigated so far. Female hairless mice were treated intraperitoneally with RvD5 before UVB stimulus. RvD5 reduced skin edema in a dose-dependent manner as well as oxidative stress by increasing antioxidants (endogenous tissue antioxidant scavenging of cationic radical, iron reduction, catalase activity and reduced glutathione levels) and decreasing pro-oxidants (superoxide anion and lipid peroxidation). RvD5 antioxidant activity was accompanied by enhancement of Nrf2, HO-1 and NQO1 mRNA expression. RvD5 reduced the production of IL-1β, TNF-α, TGF-β, and IL-10. RvD5 also reduced the inflammatory cell counts, including mast cells and neutrophils/macrophages. The reduction of oxidative stress and inflammation resulted in diminished matrix metalloproteinase 9 activity, collagen degradation, epidermal thickening and sunburn cell development. Therefore, this study demonstrates, to our knowledge, the first body of evidence that RvD5 can be used to treat UVB skin pathology and unveils, at least in part, its mechanisms of action.
- 31 July 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25 (6) , 1-12
Bioadhesive Polymeric Films Containing Rhamnolipids, An Innovative Antimicrobial Topical Formulation
Acne affects most of the world's population, causing an impact on the self-esteem of adolescents and young adults. One of the causes is the presence of
- 31 July 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25 (6) , 1-12
Bioadhesive Polymeric Films Containing Rhamnolipids, An Innovative Antimicrobial Topical Formulation
Acne affects most of the world's population, causing an impact on the self-esteem of adolescents and young adults. One of the causes is the presence of
- Open Access
- 25 October 2023
- Published by Universidade Estadual de Londrina in Semina: Ciências Biológicas e da Saúde
- Vol. 44 (2) , 171-182
A simple and rapid spectrophotometric method for the determination of trans-chalcone in raw-material and topical formulation
Trans-chalcona (TC) é um precursor de flavonoides caracterizado por um amplo espectro de ação, como efeitos anti-inflamatórios e antioxidantes. No entanto, não há método validado disponível em compêndio oficial para análise deste composto. Então, o objetivo deste trabalho foi desenvolver e validar um método espectrofotométrico, simples, rápido e reprodutível para análise de TC em matéria-prima, e em formulação farmacêutica tópica contendo TC. As condições estabelecidas foram: metanol como o solvente de extração, e detecção no comprimento de onda de 309 nm por espectrofotometria no UV. Todos os testes seguiram as normas da RDC 166, 2017. O método proposto foi seletivo. A linearidade foi demonstrada na faixa de concentração de 1 a 8 μg/mL (r = 0.999). A repetibilidade e a precisão intermediária foram confirmadas pelos valores baixos de desvio padrão relativo de 1,53% e 2,70% para a TC, e de 1,73% e 2,91% para a formulação contendo TC. A exatidão, avaliada por meio de testes de recuperação, foi adequada, com mínimo de 98,24% e máximo de 100,04% de recuperação. Observou-se que pequenas modificações no método não interferiram nos resultados, demonstrando que o método é robusto. Os resultados demonstraram que o método foi adequado para a finalidade pretendida, barato, de fácil aplicação, seletivo, linear, preciso, exato e robusto para determinação de TC, e de formulação contendo TC. Então o método desenvolvido satisfaz as necessidades de um método analítico para determinação de TC, e de formulação tópica contendo TC, e é eficaz, inovador e pode contribuir para o desenvolvimento da área farmacêutica.
- 25 October 2023
- Published by Universidade Estadual de Londrina in Semina: Ciências Biológicas e da Saúde
- Vol. 44 (2) , 171-182
Open AccessA simple and rapid spectrophotometric method for the determination of trans-chalcone in raw-material and topical formulation
Trans-chalcona (TC) é um precursor de flavonoides caracterizado por um amplo espectro de ação, como efeitos anti-inflamatórios e antioxidantes. No entanto, não há método validado disponível em compêndio oficial para análise deste composto. Então, o objetivo deste trabalho foi desenvolver e validar um método espectrofotométrico, simples, rápido e reprodutível para análise de TC em matéria-prima, e em formulação farmacêutica tópica contendo TC. As condições estabelecidas foram: metanol como o solvente de extração, e detecção no comprimento de onda de 309 nm por espectrofotometria no UV. Todos os testes seguiram as normas da RDC 166, 2017. O método proposto foi seletivo. A linearidade foi demonstrada na faixa de concentração de 1 a 8 μg/mL (r = 0.999). A repetibilidade e a precisão intermediária foram confirmadas pelos valores baixos de desvio padrão relativo de 1,53% e 2,70% para a TC, e de 1,73% e 2,91% para a formulação contendo TC. A exatidão, avaliada por meio de testes de recuperação, foi adequada, com mínimo de 98,24% e máximo de 100,04% de recuperação. Observou-se que pequenas modificações no método não interferiram nos resultados, demonstrando que o método é robusto. Os resultados demonstraram que o método foi adequado para a finalidade pretendida, barato, de fácil aplicação, seletivo, linear, preciso, exato e robusto para determinação de TC, e de formulação contendo TC. Então o método desenvolvido satisfaz as necessidades de um método analítico para determinação de TC, e de formulação tópica contendo TC, e é eficaz, inovador e pode contribuir para o desenvolvimento da área farmacêutica.